Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients
Annals of Surgical Oncology, 07/01/09
Lahat G et al. - In a study to evaluate the outcome of elderly pts amenable to complete surgical resection treated at a single institution, it seems that properly selected elderly pts can safely undergo extensive soft tissue sarcoma (STS) resections. Until more effective therapies become available, surgery in the elderly is indicated and remains the best means for STS control.
Methods- Prospectively accrued data were used to identify pts with primary STS age ≥65 yrs (n=325) who underwent complete macroscopic resection at 1 institution.
- Univariable and multivariable analyses were performed to identify prognostic factors.
- Median age at presentation was 72 yrs; 179 pts (55.1%) had associated comorbidities with an ASA score of ≥3.
- Extremity was the most common site (57.1%; n=186), undifferentiated pleomorphic sarcoma the most common histology (60.4%; n=197); 232 (71.2%) were high grade, 222 (68.3%) were >5 cm.
- 30-day postoperative mortality was 0.9% (n=3); overall complication rate was 30.7% (n=100), and mean postoperative hospital stay was 9 days.
- Estimated median survival was 96 mos, 5-yr disease-specific survival (DSS) was 63%.
- Multivariable analysis identified age ≥75 yrs, tumor size: 5–15 vs <5 cm, or >15 vs <5 cm, and high-grade as significant independent adverse prognostic factors.
- Compared with pts aged 65–74 yrs, older pts had more high-grade tumors, received chemotherapy less often, developed different patterns of recurrence, and exhibited a shorter median survival (70 mos).
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Incidence and Correlates of Radiation Dermatitis in Children and Adolescents Receiving Radiation Therapy for the Treatment of Paediatric Sarcomas
Clinical Oncology, 11/12/09
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
Annals of Oncology, 11/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


